Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

GSK plc

Tracked across 15 events · 362 articles · First seen Feb 10, 2025 · Last active Jul 06, 2026

Sentiment
16
Attention
8
Events
15
Relationships
44
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 20
Regulatory
Impact: GSK plc is among the pharmaceutical companies that agreed to lower drug prices for United States — Medicaid and cash payers as part of the deals with the Donald Trump administration.
Dec 19, 2025 · 7 articles
4 50
Tech
Impact: GSK plc is the maker of the Zoster vaccine vaccine. The study, although funded by GSK plc, was independently designed and conducted, and its positive findings regarding dementia risk reduction could enhance the company's reputation and vaccine sales.
Jun 15, 2026 · 6 articles
2 -1
Business
Impact: GSK plc is under investigation by Monteverde & Associates PC regarding its sale to GSK plc, with shareholders expected to receive $124.00 per share in cash.
May 19, 2026 · 31 articles
8 50
Business
Impact: GSK plc has adopted a more aggressive M&A approach following recent CEO transitions, contributing to the overall increase in dealmaking.
May 01, 2026 · 6 articles
8 20
Tech
Impact: GSK plc>>>'s drug Avodart is mentioned in a comparison study where GLP-1s were associated with lower rates of prostate cancer diagnoses.
Jun 02, 2026 · 45 articles
3 20
Business
Impact: GSK plc had an executive, Jeremy Pincus, recognized with an Ignite Leadership Award for driving enterprise-wide AI transformations within the company.
Jun 25, 2026 · 8 articles
6 -10
Domestic
Impact: GSK plc, a hepatitis B vaccine maker, defended its products as safe, and its shares finished 0.3% lower.
Dec 05, 2025 · 7 articles
8 75
International
Impact: GSK plc's shares rose after it agreed to acquire GSK plc for $10.6 billion, indicating positive market reception to its strategic acquisition.
Jun 03, 2026 · 191 articles
6 10
Domestic
Impact: GSK plc, as the manufacturer of Wellcovorin (a branded version of leucovorin), was asked by the United States — Food and Drug Administration to file a new application with data on cerebral folate deficiency.
Sep 22, 2025 · 6 articles
4 0
Business
Feb 20, 2026 · 6 articles
4 0
Regulatory
Mar 10, 2026 · 8 articles
6 0
Domestic
Mar 16, 2026 · 22 articles
4 0
Tech
Apr 12, 2026 · 6 articles
4 0
Tech
Apr 13, 2026 · 7 articles
4 0
Business
Apr 22, 2026 · 6 articles
ERGEN INTELLIGENCE
Track GSK plc live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.